Susanna High

Susanna High

Chief Operating Officer at DYNE THERAPEUTICS, INC.

Net worth: 195 081 $ as of 2024-04-29

56 year
Health Technology
Consumer Services
Commercial Services

Profile

Susanna G.
High
is currently the Chief Operating Officer at Dyne Therapeutics, Inc. She previously worked as the Chief Operating Officer at bluebird bio, Inc. from 2016 to 2019.
Prior to that, she was the SVP-Strategy & Business Integration at Alnylam Pharmaceuticals, Inc. from 2015 to 2016.
From 2001 to 2007, she worked as the Director-Corporate Strategy at Millennium Pharmaceuticals, Inc. Susanna's earliest job was as a Management Consultant at Accenture LLC from 1996 to 2001.
She received a graduate degree from the University of Bocconi and an MBA from MIT Sloan School of Management in 1996.

Known holdings in public companies

CompanyDateNumber of sharesValuationValuation date
2024-05-15 8,233 ( 0.01% ) 195 081 $ 2024-04-29

Susanna High active positions

CompaniesPositionStart
DYNE THERAPEUTICS, INC. Chief Operating Officer 2020-06-30
All active positions of Susanna High

Former positions of Susanna High

CompaniesPositionEnd
BLUEBIRD BIO, INC. Chief Operating Officer 2019-01-03
ALNYLAM PHARMACEUTICALS, INC. Director/Board Member 2008-05-31
Corporate Officer/Principal 2006-12-31
Corporate Officer/Principal 2000-12-31
See the detail of Susanna High's experience

Training of Susanna High

University of Bocconi Graduate Degree
MIT Sloan School of Management Masters Business Admin

Experiences
Positions held

Active

Inactive

Listed companies

Private companies

See the detail of Susanna High's experience

Connections

100 +

1st degree connections

7

1st degree companies

Male

Female

Members of the board

Executives

See the personal network

Linked companies

Listed companies3
ALNYLAM PHARMACEUTICALS, INC.

Health Technology

BLUEBIRD BIO, INC.

Health Technology

DYNE THERAPEUTICS, INC.

Health Technology

Private companies2

Health Technology

Commercial Services

See company connections